Structure of human β-glucuronidase reveals candidate lysosomal targeting and active-site motifs

Nature Structural Biology

Volumn 3, Issue 4, 1996, Pages 375-381

  Jain, Sanjeev ^a,c   Drendel, William B ^a   Chen, Zhi Wei ^b   Mathews, F Scott ^b   Sly, William S ^a   Grubb, Jeffrey H ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID HYDROLASE; BETA GLUCURONIDASE; CATHEPSIN D; LYSOSOME ENZYME;

ARTICLE; CANCER CONTROL; ENZYME ACTIVE SITE; ENZYME MECHANISM; GENE MUTATION; HUMAN; LYSOSOME; MUCOPOLYSACCHARIDOSIS TYPE 7; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; GLUCURONIDASE; HUMANS; LYSOSOMES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT;

EID: 0029878731     PISSN: 10728368     EISSN: None     Source Type: Journal    
DOI: 10.1038/nsb0496-375     Document Type: Article

References (53)

1. Paigen, K. Mammalian β-glucuronidase: Genetics, molecular biology and cell biology. Progr. Nucleic Acid Res. Molec. Biol. 37, 155-205 (1989).
2. Oshima, W. et al. Cloning, sequencing, and expression of cDNA for human β-Glucuronidase. Proc. Natl. Acad. Sci. USA 84, 685-689 (1937).
3. Shipley, J.M., Grubb, J.H. & Sly, W.S. The role of glycosylation and phosphorylation in the expression of active human β-glucuronidase. J. Biol. Chem. 268, 12193-12198 (1993).
4. Kaplan, A., Achord, D.T. & Sly, W.S. Phosphohexosyl components of a lysosomal enzyme are recognized by pinocytosis receptors on human fibroblasts. Proc. Natl. Acad. Sci. USA 74, 2026-2030 (1977).
5. Natowicz, M.R., Chi, M.M.-Y., Lowry, O.H. & Sly, W.S. Enzymatic identification of mannose-6-phosphate on the recognition marker for receptor-mediated pinocytosis of β-Glucuronidase by human fibroblasts. Proc. Natl. Acad. Sci. USA 76, 4322-4326 (1979).
6. Dahms, N.M., Lobel, P. & Kornfeld, S. Mannose 6-phosphate receptors and lysosomal enzyme targeting. J. Biol. Chem. 264, 12115-12118 (1989).
7. Reitman, M.L. & Kornfeld, S. UDP-N-acetylglucosamine: Glycoprotein N- acetylglucosamine-1-phosphotransferase, proposed enzyme for the phosphorylation of the high mannose oligosaccharide units of lysosomal enzymes. J. Biol. Chem. 256, 4275-4281 (1981).
8. Waheed, A., Hasilik, A. & von Figura, K. Processing of the phosphorylated recognition marker in lysosomal enzymes. J. Biol. Chem. 256, 5717-5721 (1981).
9. Lang, L., Reitman, M.L., Tang, J., Roberts, R.M. & Kornfeld, S. Recognition of a protein-dependent determinant allows specific phosphorylation of oligosaccharides present on lysosomal enzymes. J. Biol. Chem. 259, 14663-14671 (1984).
10. Baranski, T.J., Faust, P.L. & Kornfeld, S. Generation of a lysosomal enzyme targeting signal in the secretory protein pepsinogen. Cell 63, 281-291 (1990).
11. Baranski, T.J., Koelsch, G., Hartsuck, J.A. & Kornfeld, S. Mapping and molecular modeling of a recognition domain for lysosomal enzyme targeting. J. Biol. Chem. 266, 23365-23372 (1991).
12. Metcalf, P. & Fusek, M. Two crystal structure for cathepsin D: The lysosomal targeting signal and active site. EMBO J. 12, 1293-1302 (1993).
13. Musil, D. et al. The refined 2.15 Å x-ray crystal structure of human liver cathepsin B: The structural basis for its specificity. EMBO J. 10, 2321-2330 (1991).
14. Jia, Z. et al. Crystal structure of recombinant rat cathepsin B and a cathepsin B-inhibttor complex. Implications for structure-based inhibitor design. J. Biol. Chem. 270, 5527-5533 (1995)
15. Lin, X., Dashti, A., Schinazi, R.F. & Tang, J. Intracellular diversion of glycoprotein GP160 of human immunodeficiency virus to lysosomes as a strategy of AIDS gene therapy. FASEB J. 7, 1070-1080 (1993)..
16. Bosslet, K. et al. Molecular and functional characterization of a fusion protein suited for tumor specific prodrug activation. Br. J. Cancer 65, 234-238 (1992).
17. Bosslet, K., Czech, J. & Hoffman, D. Tumor-selective prodrug activation by fusion protein-mediated catalysis. Cancer Res. 54, 2151-2159 (1994).
18. Caygill, J.C. & Pitkeathy, D.A. A Study of β-Acetylglucosaminase and acid phosphatase in pathological joint fluids. Ann. Rheum. Dis. 25, 137-145 (1965).
19. Weissman, G., Zurier, R.B. & Spieler, P.Z. Mechanisms of lysosomal enzyme release from leukocytes exposed to immune complexes and other particles. J. Exp. Med. 134, 521-536 (1971).
20. Boyer, M.J., & Tannock, I.F. Lysosomes, lysosomal enzymes, and cancer. Adv. Cancer Res. 60, 269-291 (1993).
21. Kinoshita, N. & Gelboin, H.V. β-Glucuronidase catalyzed hydrolysis of benzo[a]pyrene-3- glucuronide and binding to DNA. Science 199, 307-309 (1978).
22. Kim, D.-H., Kang, H.-J., Park, S.-H. & Kobashi, K. Characterization of β-glucosidase and β-glucuronidase of alkalotolerant intestinal bacteria. Biol. Pharm. Bull. 17, 423-426 (1994).
23. Sly, W.S., Quinton, B.A., McAlister, W.H. & Rimoin, D.L. Beta-glucuronidase deficiency: Report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis. J. Pediatr. 82, 249-257 (1973).
24. Tomatsu, S. et al. Mucopolysaccharidosis type VII: Characterization of mutations and molecular heterogeneity. Am. J. Hum. Genet 48, 89-96 (1991).
25. Shipley, J.M. et al. Mutational analysis of a patient with mucopolysaccharidosis type VII, and identification of pseudogenes. Am. J. Hum. Genet. 52, 517-526 (1993).
26. Wu, B.M., Tomatsu, S., Sukegawa, K., Orii, T. & Sly, W.S. Overexpression rescues the mutant phenotype of I176f mutation causing β-glucuronidase deficiency mucopolysaccharidosis in two Mennonite siblings. J. Biol. Chem. 269, 23681-23688 (1994).
27. Vervoort, R., Lissens, W. & Liebaers, I. Molecular analysis of a patient with hydrops fatalis caused by β-glucuronidase deficiency, and evidence for additional pseudogenes. Hum. Mutat. 2, 443-445 (1993).
28. Drendel, W.B. et al. Crystallization and Preliminary Crystallographic Studies of Human β-Glucuronidase. J. Mol. Biol. 233, 173-176 (1993).
29. Brünger, A.T. The free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355, 472-474 (1992).
30. Hardman, K.D. & Ainsworth, C.F. Structure of concavalin A at 2.4 Å resolution. Biochem. 11, 4910-4919 (1972).
31. Alzari, P.N., Lascombe, M.-B. & Poljak, R.J. Three dimensional structure of antibodies. Annu. Rev. Immunol. 6, 555-580 (1988).
32. Muirhead, H. Triose phosphate isomerase, pyruvate kinase and other α/β-barrel enzymes. Trends Biochem. Sci. 8, 326-330 (1983).
33. Jacobson, R.H., Zhang, X.-J., DuBose, R.F. & Matthews, B.W. Three-dimensional structure of β-galactosidase from E. Coli. Nature 369, 761-766 (1994).
34. Faust, P. Lysosomal enzyme phosphorylation: analysis of the lysosomal enzyme protein recognition domain in the aspartyl protease gene family. Ph.D. Dissertation, Washington University School of Medicine, St. Louis, MO (1988).
35. Cuozzo, J.W., Tao, K., Wu, Q., Young, W. & Sahagian, G.G. Lysine-based structure in the proregion of procathepsin I is the recognition site for mannose phosphorylation. J. Biol. Chem. 270, 15611-15619 (1995).
36. Schorey, J.S., Fortenberry, S.C. & Chirgwin, J.M. Lysine residues in the C-terminal lobe and lysosomal targeting of procathepsin D. J. Cell Sci. 108, 2007-2015 (1995).
37. Wang, C.-C. & Touster, O. Studies of catalysis by β-glucuronidase. J. Biol. Chem. 247, 2644-2656 (1972).
38. Ring, M. & Huber, R.E. Multiple replacements establish the Importance of tyrosine-503 in β-galactosidase (Escherichia coli. Arch. Biochem. Biophys. 283, 342-350 (1990).
39. Cupples, C.G., Miller, J.H. & Huber, R.E. Determination of the roles of Glu-461 in β- galactosidase (Escherichia coli) using site-specific mutagenesis. J. Biol. Chem. 265, 5512-5518 (1990).
40. Gebler, J.C., Aebersold, R. & Withers, S.G. Glu-537, not Glu-461, is the nucleophile in the active site of (lacZ) β-galactosidase from Escherichia coli. J. Biol. Chem. 267, 11126-11130 (1992).
41. Phillips, D.C. The three dimensional structure of an enzyme molecule. Sci. Amer. 215 (5), 78-90 (1966).
42. Jefferson, R.A., Burgess, S.M. & Hirsh, D. β-glucuronidase from Escherichia coil as a gene-fusion marker. Proc. Natl. Acad. Sci. USA 83, 8447-8451 (1986).
43. Russel, A.J. & Fersht, A.R. Rational modification of enzyme catalysis by engineering surface charge. Nature 328, 496-500 (1987).
44. Gehrmann, M.C., Opper, M., Sedlacek, H.H., Bosslet, K. & Czech, J. Biochemical properties of recombinant human β-glucuronidase synthesized in baby hamster kidney cells. Biochem. J. 301, 821-828 (1994).
45. Watenpaugh, D.D. Overview of phasing by isomorphous replacement. Methods Inzymol. 115, 3-15 (1985).
46. Lebioda, L. & Zhang, E. Soaking of crystals for macromolecular crystallography in a capillary. J. Appl. Crystallogr. 25, 323-324 (1992).
47. Zhang, K.Y.J. SQUASH - Combining constrains for macromolecular phase refinement and extension. Acta Crystallogr. D49, 213-222 (1993).
48. Islam, M.R., Grubb, J.H. & Sly, W.S. C-terminal processing of human β-glucuronidase: The propeptide is required for full expression of catalytic activity, intracellular retention, and proper phosphorylation. J. Biol. Chem. 268, 22627-22632 (1993).
49. Sack, J.S. CHAIN - a Crystallographic modeling program. J. Mol. Graphics 6, 224-235 (1988).
50. Brunger, A. X-PLOR version 3.1, Yale University Press, New Haven, CT (1992).
51. Engh, R.A. & Huber, R. Accurate bond and angle parameters for x-ray protein structure refinement. Acta Crystallogr. A47, 392-400 (1991).
52. Devereux, J., Haeberli, P. & Smithies. O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Research. 12, 387 (1984).
53. Kraulis, P.J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950 (1991).